Growth Metrics

Nuwellis (NUWE) Long-Term Debt Repayments (2015 - 2016)

Nuwellis posted quarterly Long-Term Debt Repayments of $6.1 million for Q3 2016, up 115.34% on a QoQ basis from $2.8 million in Q2 2016.

Nuwellis (NUWE) has 2 years of Long-Term Debt Repayments data on file, last reported at $6.1 million in Q3 2016.

  • For the quarter ending Q3 2016, Long-Term Debt Repayments changed N/A year-over-year to $6.1 million; the trailing twelve-month figure through Dec 2017 stood at $6.1 million (down 23.69% YoY), and the FY2016 full-year result was $8.0 million, changed N/A from the prior year.
  • Long-Term Debt Repayments for Q3 2016 stood at $6.1 million, up from $2.8 million in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $6.1 million in Q3 2016 and bottomed at -$940000.0 in Q1 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Repayments (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.42 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 1.00 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Nuwellis 1.45 Mn -630,292.49 1.68 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2016 6.11 Mn
Sep 30, 2016 6.11 Mn
Jun 30, 2016 2.84 Mn
Jun 30, 2016 2.84 Mn
Mar 31, 2016 -940,000.00
Mar 31, 2016 -940,000.00
Mar 31, 2015 6.00 Mn
Mar 31, 2015 6.00 Mn